Recent

% | $
Quotes you view appear here for quick access.

Dendreon Corporation Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • kinaseman kinaseman Mar 11, 2012 8:13 PM Flag

    Re: zytiga would never have reached stat sig even against placebo...

    The gold standard finally adopted by the FDA is Overall Survival... PFS is only a surrogate for OS... The fact that JNJ agreed to halt the trial before stat sig reached implies it will never be reached and the KM curve was deteriorating... Any clinical physician that gets behind this move and purports that this is good should be investigated because from a clinical outcome perspective, the likelihood of improving on the the significance is all but gone with he crossover... The best they could do now is have to do another study... If the clinical oncologists back this they should be made to answer why... No way zytiga ever reaches stat sig and the hedgies that are paying for media bashing are quite honestly are trying to put a positive spin on negative data... When KM curves start to converge, you're going to get high p values and negative bias... That is the reason this wad stopped... It has nothing to do with helping patients... The truth will prevail... Scripts fir Q1 will provide blowout numbers... See you on the otherwise of the gap, $35.84... FU Milken, Cramer, Morgan Joseph and the rest of the Milen-Boesky cronies...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
DNDN
0.1270.000(0.00%)Nov 18 4:00 PMEST